Related Experiment Video
Updated: Oct 25, 2025
10:36
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
10.7K
Estrogen Receptor ß in Cancer: To ß(e) or not to ß(e)?
Nicole M Hwang1,2, Laura P Stabile1,2
1Department of Pharmacology and Chemical Biology, University of Pittsburgh, PA 15261, USA.
Endocrinology
|August 9, 2021
Summary
Estrogen receptor beta (ERβ) plays a complex role in cancer. While often protective, its expression is linked to worse outcomes in lung cancer, highlighting its varied functions.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Estrogen receptors (ERs) are crucial for reproductive organ development and cancer progression.
- Estrogen receptor alpha (ERα) is extensively studied in breast cancer.
- Estrogen receptor beta (ERβ) shows varied roles, often protective but linked to poor prognosis in lung cancer.
Purpose of the Study:
- To review the literature on ERβ's mechanisms and clinical implications.
- To explore ERβ's dual role in different cancer types.
- To understand the complexities of ERβ function in cancer.
Main Methods:
- Literature review of current research on ERβ.
- Analysis of ERβ's mechanism of action in various cancers.
- Examination of clinical implications of ERβ expression.
Main Results:
- ERβ exhibits antitumor activity in breast, ovarian, and prostate cancers.
- ERβ loss is associated with oncogenesis and cancer progression.
- ERβ expression correlates with disease progression and poor prognosis in lung cancer.
Conclusions:
- ERβ's function is complex, influenced by isoforms, SNPs, and tissue specificity.
- Understanding ERβ's multifaceted role is critical for cancer treatment strategies.
- Further research is needed to elucidate ERβ's precise impact across different malignancies.
More Related Videos
Related Concept Videos
02:38Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
01:15Receptor Downregulation in MVBs
2.4K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.4K
01:31Transducer Mechanism: Nuclear Receptors
1.9K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.9K
01:20The Retinoblastoma Gene
4.3K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
01:23Negative Regulator Molecules
36.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K